Teva: It’s Never Too Late to Sell
November 13, 2017 at 11:48 AM EST
It was just two months ago that Teva Pharmaceutical Industries (TEVA) hired Kare Schultz as its new CEO, ending months of speculation about who would be tasked to steer the troubled specialty drug maker. Teva Pharmaceutical Industries’ multiple sclerosis drug Copaxone Teva Pharmaceutical Industries But J.P. Morgan’s Chris Schott warns that there are no quick fixes […]